https://imedsciences.com/ editor_ijims@hotmail.com
ISSN: 2394-4137 (E) 2394-6318 (P)

IJIMS.2016.124

Type of Article: Review

Volume 3; Issue 9: September 2016

Page No.: 404-411

DOI: 10.16965/ijims.2016.124

Prevention of Cardiovascular Disease by Dietary n-3 Fatty Acid

B. Raghu.

Associate Professor, International Medical School, Management and Science University, Shah Alam 40100, Malaysia.

CORRESPONDING AUTHOR ADDRESS: B. Raghu, Associate Professor, International Medical School, Management and Science University, Shah Alam 40100, Malaysia. E-Mail: vasuraghu@hotmail.com

ABSTRACT

Cardiovascular disease (CVD) is a main cause of morbidity and mortality worldwide. Its prevention through a healthy lifestyle and appropriate diet is important. Omega-3 polyunsaturated fatty acids (n-3 PUFA) therapy has shown promise in both primary and secondary prevention of CVD. This commentary reviews the nutritional role of n-3 PUFA, including its metabolism and physiological role, comparison to n-6 series PUFA, as well as complications due to deficiency. Clinical use of n-3 PUFA for the prevention and treatment of CVD, recommended intake and potential adverse effects will also be examined. The available scientific evidence suggests that its supplementation and clinical use ranging from 0.4 to 7g/day can provide tangible benefits. However, further studies are required to determine optimal dosing and the relative ratio of docosahexaenoic acid and eicosapentaenoic acid that provides maximal cardio-protection and treatment of CVD.

Key words: Alpha-Linolenic Acid, Docosahexaenoic Acid, Eicosapentaenoic Acid, Cardiovascular Disease, Fish Oil, Polyunsaturated Fatty Acids.

REFERENCES

  1. World Health Organization. Cardiovascular diseases (CVDs). Available from: http://www.who.int/mediacentre/factsheets/fs317/en/index.html
  2. Centers for Disease Control and Prevention. Heart Disease and Stroke Prevention. Addressing the nation’s leading killers: at a glance 2010. Available from: http://www.cdc.gov/chronicdisease/resources/publications/AAG/dhdsp.htm
  3. National Heart Foundation of Australia. Data and statistics. Available from: http://www.heartfoundation.org.au/information-for-professionals/data-and-statistics.
  4. Mozaffarian D. JELIS, fish oil and cardiac events. Lancet. 2007;369(9567):1062-1063.
  5. Meyer BJ. Are we consuming enough long chain omega-3 polyunsaturated fatty acids for optimal health? Prostaglandins Leukot Essent Fatty Acids. 2011;DOI: 10.1016/j.plefa.2011.04.010.
  6. Chan EJ, Cho L. What can we expect from omega-3 fatty acids? Cleve Clin J Med. 2009;76(4):245-251.
  7. Russo GL. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol. 2009;77(6):937-946.
  8. Stillwell W, Wassall SR. Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids. 2003;126(1):1-27.
  9. Innis SM. Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J Pediatr. 2003;143(4 Suppl):S1-S8.
  10. Kalmijin S. Fatty acid intake and the risk of dementia and cognitive decline: a review of clinical and epidemiological studies. J Nutr Health Aging. 2000;4(4):202-207.
  11. Sampath H, Ntambi JM. Polyunsaturated fatty acid regulation of gene expression. Nutr Rev. 2004;62(9):333-339.
  12. International Society for the Study of Fatty Acids and Lipids. Recommendations for intake of polyunsaturated fatty acids in healthy adults. Available from: http://www.issfal.org
  13. Calzolari I, Fumagalli S, Marchionni N, Di Bari M. Polyunsaturated fatty acids and cardiovascular disease. Curr Pharm Des. 2009;15(36):4094-4102.
  14. Jeppesen PB, Hoy CE, Mortensen PB. Essential fatty acid deficiency in patients receiving home parenteral nutrition. Am J Clin Nutr. 1998;68(1):126-133.
  15. Lafourcade M, Larrieu T, Mato S, et al. Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat Neurosci. 2011;14(3):345-350.
  16. Okuyama H. High n-6 to n-3 ratio of dietary fatty acids rather than serum cholesterol as a major risk factor for coronary heart disease. Eur J Lipid Sci Technol. 2001;103(6):418-422.
  17. Griffin BA. How relevant is the ratio of dietary n-6 to n-3 polyunsaturated fatty acids to cardiovascular disease risk? Evidence from the OPTILIP study. Curr Opin Lipidol. 2008;19(1):57-62.
  18. Tribole EF, Thompson RL, Harrison RA, et al. Excess omega-6 fats thwart health benefits from omega-3 fats. BMJ. 2006;332(7544):752–760.
  19. Adkins Y, Kelley DS. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. J Nutr Biochem. 2010;21(9):781-792.
  20. Willett WC. The role of dietary n-6 fatty acids in the prevention of cardiovascular disease. J Cardiovasc Med. (Hagerstown). 2007;8 Suppl 1:S42-S45.
  21. Mozaffarian D, Ascherio A, Hu FB, et al. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation. 2005;111(2):157-164.
  22. Japanese Ministry of Health, Labour and Welfare. Dietary Reference Intakes for Japanese(2010edition).
  23. Available from: http://www.mhlw.go.jp/bunya/kenkou/sessyu-kijun.htmlAmbring A, Johansson M, Axeisen M, Gan L, Strandvik B, Friberg P. Mediterranean-inspired diet lowers the ratio of serum phospholipid n-6 to n-3 fatty acids, the number of leukocytes and platelets, and vascular endothelial growth factor in healthy subjects. Am J Clin Nutr. 2006;83(3):575-581.
  24. Iso H, Kobayashi M, Ishihara J, et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation. 2006;113(2):195-202.
  25. Harris WS. The omega-3 index as a risk factor for coronary heart disease. Am J Clin Nutr. 2008;87(6):1997S-2002S.
  26. Harris WS. The omega-3 index: from biomarker to risk marker to risk factor. Curr Atheroscler Rep. 2009;11(6):411-417.
  27. Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol. 2009;54(7):585-594.
  28. Patel JV, Tracey I, Hughes EA, Lip GY. Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy. Vasc Health Risk Manag. 2009;5:801-810.
  29. Yamagishi K, Iso H, Date C, et al. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J Am Coll Cardiol. 2008;52(12):988-996.
  30. Hooper L, Thompson RL, Harrison R A, et al. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev. 2004;18(4):CD003177.
  31. Studer M, Briel M, Leimenstoll B, Glass TR, Bucher HC. Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med. 2005;165(7):725-730.
  32. Wang C, Harris WS, Chung M, et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr. 2006;84(1):5-17.
  33. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on coronary restenosis, intima-media thickness, and exercise tolerance: A systematic review. Atherosclerosis. 2006;184(2):237-246.
  34. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis. 2006;189(1):19-30.
  35. Castro IA, Barroso LP, Sinnecker P. Functional foods for coronary heart disease risk reduction: a meta-analysis using a multivariate approach. Am J Clin Nutr. 2005;82(1):32-40.
  36. Eslick GD, Howe PRC, Smith C, Priest R, Bensoussan A. Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Int J Cardiol. 2009;136(1):4-16.
  37. Lee KW, Lip GY. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med. 2003;163(19):2368-2392.
  38. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77(5):1146-1155.
  39. Wendland E, Farmer A, Glasziou P, Neil A. Effect of alpha linolenic acid on cardiovascular risk markers: a systematic review. Heart. 2006;92(2):166-169.
  40. Richard D, Bausero P, Schneider C, Visioli F. Polyunsaturated fatty acids and cardiovascular disease. Cell Mol Life Sci. 2009;66(20):3277-3288.
  41. Massaro M, Scoditti E, Carluccio MA, De Caterina R. Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. Prostaglandins Leukot Essent Fatty Acids. 2008;79(3-5):109-115.
  42. Watts GF, Mori TA. Recent advances in understanding the role and use of marine w3 polyunsaturated fatty acids in cardiovascular protection. Curr Opin Lipidol. 2011;22(1): 70-71.
  43. Kris-Etherton PM, Harris WS, Appel LJ; for American Heart Association Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. 2002;106(21):2747-2757.
  44. National Heart Foundation of Australia. Position statement: Fish, fish oils, n-3 polyunsaturated fatty acids and cardiovascular health. Updated November 2008. Available from: www.heartfoundation.org.au
  45. National Health and Medical Research Council. Nutrient reference values for Australia and New Zealand including recommended dietary intakes. Canberra: Australian Government Department of Health and Ageing; 2006.
  46. USDA Agricultural Research Service. Nutrient Data Laboratory. Available from: http://www.ars.usda.gov/nutrientdata
  47. Saravanan P, Davidson NC, Schmidt EB, Calder PC. Cardiovascular effects of marine omega-3 fatty acids. Lancet. 2010;376(9740):540-550.
  48. American Heart Association. Fish and Omega-3 Fatty Acids. Available from: http://www.amhrt.org/HEARTORG/GettingHealthy/NutritionCenter/HealthyDietGoals/Fish-and-Omega-3-Fatty-Acids_UCM_303248_Article.jsp
  49. Raghu. and P. Venkatesan. Effect of n-3 fatty acid supplementation on blood glucose , lipid profile and cytokines in humans. A pilot study. Ind. J. Clin. Biochem. 2008;23(1):85-88.
  50. B.Raghu and P.Venkatesan. Relationship between cigarette smoking and novel risk factors for cardiovascular disease. Journal of Biomedical Sciences. 2012;1:1-4.
Download Full Text TOC